» Articles » PMID: 26154151

A Novel Long Non-coding Natural Antisense RNA is a Negative Regulator of Nos1 Gene Expression

Overview
Journal Sci Rep
Specialty Science
Date 2015 Jul 9
PMID 26154151
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Long non-coding natural antisense transcripts (NATs) are widespread in eukaryotic species. Although recent studies indicate that long NATs are engaged in the regulation of gene expression, the precise functional roles of the vast majority of them are unknown. Here we report that a long NAT (Mm-antiNos1 RNA) complementary to mRNA encoding the neuronal isoform of nitric oxide synthase (Nos1) is expressed in the mouse brain and is transcribed from the non-template strand of the Nos1 locus. Nos1 produces nitric oxide (NO), a major signaling molecule in the CNS implicated in many important functions including neuronal differentiation and memory formation. We show that the newly discovered NAT negatively regulates Nos1 gene expression. Moreover, our quantitative studies of the temporal expression profiles of Mm-antiNos1 RNA in the mouse brain during embryonic development and postnatal life indicate that it may be involved in the regulation of NO-dependent neurogenesis.

Citing Articles

Time dependent differential regulation of a novel long non-coding natural antisense RNA during long-term memory formation.

Korneev S, Garaliene J, Taylor G, Kemenes I, Kemenes G Sci Rep. 2021; 11(1):3594.

PMID: 33574420 PMC: 7878882. DOI: 10.1038/s41598-021-83190-4.


The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2.

Sun D, Wang Y, Wang H, Xin Y Cancer Cell Int. 2020; 20:204.

PMID: 32514249 PMC: 7260745. DOI: 10.1186/s12935-020-01285-w.


The temporal expression profile of a Nos3-related natural antisense RNA in the brain suggests a possible role in neurogenesis.

Chavez G, Taylor G, Garaliene J, Richardson G, Korneev S Nitric Oxide. 2017; 71:27-31.

PMID: 29031735 PMC: 5714617. DOI: 10.1016/j.niox.2017.10.002.


Transcriptional interference by RNA polymerase III affects expression of the gene.

Yeganeh M, Praz V, Cousin P, Hernandez N Genes Dev. 2017; 31(4):413-421.

PMID: 28289142 PMC: 5358760. DOI: 10.1101/gad.293324.116.


Human Ischemic Cardiomyopathy Shows Cardiac Nos1 Translocation and its Increased Levels are Related to Left Ventricular Performance.

Rosello-Lleti E, Carnicer R, Tarazon E, Ortega A, Gil-Cayuela C, Lago F Sci Rep. 2016; 6:24060.

PMID: 27041589 PMC: 4819187. DOI: 10.1038/srep24060.

References
1.
Zhang Y, Li J, Kong L, Gao G, Liu Q, Wei L . NATsDB: Natural Antisense Transcripts DataBase. Nucleic Acids Res. 2006; 35(Database issue):D156-61. PMC: 1635336. DOI: 10.1093/nar/gkl782. View

2.
Bredt D, Snyder S . Nitric oxide, a novel neuronal messenger. Neuron. 1992; 8(1):3-11. DOI: 10.1016/0896-6273(92)90104-l. View

3.
Faghihi M, Modarresi F, Khalil A, Wood D, Sahagan B, Morgan T . Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med. 2008; 14(7):723-30. PMC: 2826895. DOI: 10.1038/nm1784. View

4.
Garthwaite J . Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci. 2008; 27(11):2783-802. PMC: 2610389. DOI: 10.1111/j.1460-9568.2008.06285.x. View

5.
Evangelopoulos M, Weis J, Kruttgen A . Signalling pathways leading to neuroblastoma differentiation after serum withdrawal: HDL blocks neuroblastoma differentiation by inhibition of EGFR. Oncogene. 2005; 24(20):3309-18. DOI: 10.1038/sj.onc.1208494. View